Seeking Alpha

Ligand Pharmaceuticals (LGND -2.3%) trades lower after guiding its FY13 estimates below Street...

Ligand Pharmaceuticals (LGND -2.3%) trades lower after guiding its FY13 estimates below Street consensus at its Analyst Day earlier this morning. The company now expects earn around $0.35 per share on revenue of $41M to $44M, below analysts estimates of $0.43 on $45M. (Webcast replay)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector